Evidence map›Paper›PMID 30359347›Full record

ArticleMMWR. Morbidity and mortality weekly report2018

Update: Influenza Activity - United States and Worldwide, May 20-October 13, 2018.

Eric J Chow, C Todd Davis, Anwar Isa Abd Elal, Noreen Alabi, Eduardo Azziz-Baumgartner, John Barnes, Lenee Blanton, Lynnette Brammer, Alicia P Budd, Erin Burns and 20 more

Open access · bronzeAbstract read
In one paragraph

Article in MMWR. Morbidity and mortality weekly report, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Detection and discrimination of influenza B Victoria lineage deletion variant viruses by real-time RT-PCR.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Article
  7. Article
  8. Vaccination in the Elderly and IBD.Current treatment options in gastroenterology · 2019
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Eric J Chow
C Todd Davis
Anwar Isa Abd Elal
Noreen Alabi
Eduardo Azziz-Baumgartner
John Barnes
Lenee Blanton
Lynnette Brammer
Alicia P Budd
Erin Burns
William W Davis
Vivien G Dugan
Alicia M Fry
Rebecca Garten
Lisa A Grohskopf
Larisa Gubareva
Yunho Jang
Joyce Jones
Krista Kniss
Stephen Lindstrom
Desiree Mustaquim
Rachael Porter
Melissa Rolfes
Wendy Sessions
Calli Taylor
David E Wentworth
Xiyan Xu
Natosha Zanders
Jacqueline Katz
Daniel Jernigan

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During May 20-October 13, 2018,* low levels of influenza activity were reported in the United States, with a mix of influenza A and B viruses circulating. Seasonal influenza activity in the Southern Hemisphere was low overall, with influenza A(H1N1)pdm09 predominating in many regions. Antigenic testing of available influenza A and B viruses indicated that no significant antigenic drift in circulating viruses had emerged. In late September, the components for the 2019 Southern Hemisphere influenza vaccine were selected and included an incremental update to the A(H3N2) vaccine virus used in egg-based vaccine manufacturing; no change was recommended for the A(H3N2) component of cell-manufactured or recombinant influenza vaccines. Annual influenza vaccination is the best method for preventing influenza illness and its complications, and all persons aged ≥6 months who do not have contraindications should receive influenza vaccine, preferably before the onset of influenza circulation in their community, which often begins in October and peaks during December-February. Health care providers should offer vaccination by the end of October and should continue to recommend and administer influenza vaccine to previously unvaccinated patients throughout the 2018-19 influenza season (1). In addition, during May 20-October 13, a small number of nonhuman influenza "variant" virus infections

Indexed as

Disease OutbreaksPopulation SurveillanceDrug Resistance, ViralGlobal HealthHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H1N2 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza B virusInfluenza, HumanInfluenza VaccinesSeasonsUnited StatesInfluenza Vaccines

Identifiers

PMID30359347
PMCPMC6290813
OpenAlexW2898329040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.